G1 therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Research triangle park, n.c., june 05, 2024 (globe newswire) -- g1 therapeutics, inc. (nasdaq: gthx ), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 4,650 shares of g1's common stock and 2,400 restricted stock units (rsus) to one hired employee under the amended and restated g1 therapeutics, inc. 2021 inducement equity incentive plan (the “amended and restated 2021 plan”).
NDAQ Ratings Summary
NDAQ Quant Ranking